Back to top

Canaccord Genuity Reaffirms Their Buy Rating on Integral Diagnostics Ltd. (IDX)

Canaccord Genuity analyst maintained a Buy rating on Integral Diagnostics Ltd. today and set a price target of A$3.40. The company’s shares closed ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

VanEck Indonesia Index ETF (IDX)